H. Park

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

H. Park is an author at University of Milan specializing in metastatic gastrointestinal cancer, her2-positive breast cancer immunotherapy, and her2-positive metastatic disease.

Publications per year

2021–2021

Publications

LBA55 Primary analysis of a phase II single-arm trial of trastuzumab deruxtecan (T-DXd) in western patients (Pts) with HER2-positive (HER2+) unresectable or metastatic gastric or gastroesophageal junction (GEJ) cancer who progressed on or after a trastuzumab-containing regimen

Eric Van Cutsem, Maria Di Bartolomeo, E.C. Smyth et al. · Annals of Oncology · 2021 · 28 citations

Medicine, Oncology, Pharmacotherapy +17

1–1 of 1